One FTSE 100 and one FTSE 250 growth stock I would buy with £2,000 today

Harvey Jones tips a FTSE 100 (INDEXFTSE: UKX) stock and one from the FTSE 250 (INDEXFTSE: MCX), both with growth prospects and scope for dividend progression.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A little money can go a long way if you invest in the right company. Splitting £1,000 between these two stocks could prove a rewarding two-way bet.

In its element

FTSE 250 chemicals specialist Elementis (LSE: ELM) is making a splash this morning, its share price up 6.23% on publication of its AGM trading statement headlined “Solid start to the year, confident of further progress in 2018”. The group’s Personal Care division, which manufactures hectorite-based products for the cosmetics market, is enjoying growth across new product categories and geographies. I find this particularly encouraging because although it makes up less than 10% of the business, it enjoys higher margins.

Its Coatings operation is expanding in EMEA and the Americas, with a steady performance in Asia, while its Energy division remains solid despite strong comparatives. Chromium is recovering after exceptional weather conditions at the group’s Castle Hayne plant knocked Q1 output.

Chemicals brothers

Today’s brief statement noted that strong free cash generation continued in Q1 while net debt reduced, helped by the disposal of its Surfactants business in March. “Our financial platform is robust and supportive of future growth and continued shareholder value creation,” the £1.39bn group added.

Elementis is one of the UK’s largest speciality chemicals and personal care businesses, with extensive operations in the US, Europe and Asia. City analysts reckon its earnings per share (EPS) will grow a healthy 13% across 2018, then another 9% in 2019. By then, the yield should climb to 2.6%, which is solid but not extravagant. However, my Foolish colleague Peter Stephens recently noted that Elementis pays out just 43% of profits to shareholders, and could increase this percentage as profits grow. Today’s 2.4% yield is covered 2.2 times, which also suggests scope for progression.

However, I am not the first to spot its potential, Elementis is currently trading at a slightly toppy forecast valuation of 19.5 times earnings.

Information is power

Global information and analytics company Relx (LSE: REL) has had mixed fortunes lately, suffering a 17% share price drop in the autumn. The group was punished by adverse currency movements, a slew of broker downgrades, and worries around its scientific information division, but the response may have been overdone and investors may still have a buying opportunity here.

Relx is a subscription-driven business with a stable customer base across the scientific, legal and insurance markets, giving it strong and steady cash flows. EPS growth looks set to slow after four rampant years but should still clock in at 4% this year and 5% in 2019. By then, the yield should have climbed to a solid 2.9%. Covered two times, there is scope for dividend progression here as well.

Time to Relx

Earlier this month, management reported that year-to-date business trends remain consistent with full-year 2017, while the business is enjoying organic development, and has also completed four acquisitions totalling £668m. It completed £325m of the previously announced £700m share buyback, with the remainder due this year.

Recently patchy share price performance may suggest the company is a victim of its own success, but the sell-off has trimmed its toppy valuation to 18.6 times earnings. Relx is still a little pricey, but a better deal than before.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has recommended Elementis and RELX. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

My Diageo shares stink! What should I do with them?

Diageo shares are having a negative impact on Edward Sheldon’s investment portfolio at the moment. Should he cut his losses…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

5 things that make me nervous about Barclays shares!

After more than doubling over the past year, Barclays shares are riding high. But the road ahead could be bumpy…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

3 reasons the NatWest share price could keep climbing

The NatWest share price has almost doubled in the last 12 months. But Stephen Wright thinks it might not be…

Read more »

Investing Articles

Billionaire’s hedge fund bets big against the GSK share price!

After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest…

Read more »

Investing Articles

Now at a 52-week high, can the Scottish Mortgage share price go even higher?

The Scottish Mortgage share price is firing on all cylinders, driven higher by outstanding progress at many of the trust's…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

FTSE shares: the perfect ‘get rich slow’ idea?

As a long-term investor, Christopher Ruane reckons the FTSE 100 could offer him the foundations to create stock market wealth.…

Read more »

Investing Articles

Here’s how an investor in their 30s could aim to turn a £10k ISA into £132,676 by retirement

Christopher Ruane explains how someone with a 30-year investing timeframe could aim to increase an ISA stuffed with blue-chip shares…

Read more »

Investing Articles

£10,000 invested in Rolls-Royce shares 5 years ago is now worth…

Rolls-Royce shares have made a lot of investors very rich as they push to new heights. Dr James Fox explores…

Read more »